Synthetic MVA-based SARS-CoV-2 Vaccine GEO-CM04S1

Preferred Label : Synthetic MVA-based SARS-CoV-2 Vaccine GEO-CM04S1;

NCIt synonyms : sMVA-based SARS-CoV-2 Vaccine COH04S1; SARS-CoV-2 Vaccine COH04S1; Synthetic MVA-based SARS-CoV-2 Vaccine COH04S1;

NCIt definition : A vaccine comprised of a synthetic modified Vaccinia virus Ankara (sMVA) viral vector encoding the two severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) surface antigens spike (S) and nucleocapsid (N) proteins, with potential immunizing activity against SARS-CoV-2. Upon administration of the sMVA-based SARS-CoV-2 vaccine GEO-CM04S1, the SARS-CoV-2 S and N proteins are expressed in cells and presented to the immune system. This may activate both humoral and cellular immune responses which may result in protection against SARS-CoV-2 infection.;

Molecule name : COH04S1; GEO CM04S1; GEO-CM04S1;

NCI Metathesaurus CUI : CL1642401;

Details

Origin ID

C176570;

UMLS CUI

C5447311;

Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- COH04S1 COVID-19 vaccine [MeSH Supplementary Concept]
concept_is_in_subset
- CTRP Agent Terminology [NCIt concept]
- CTRP Terminology [NCIt concept]
- NCI Drug Dictionary Terminology [NCIt concept]
- NCIt COVID-19 Agent Terminology [NCIt concept]
- NCIt COVID-19 Terminology [NCIt concept]
has_target
- SARS-CoV-2 Nucleoprotein [NCIt concept]
- SARS-CoV-2 Spike Glycoprotein [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients